Here are five points:
1. Before the offer, Stryker owned more than 50 percent of VEXIM’s share capital and voting rights.
2. During the offer, Stryker acquired 4,036,406 more VEXIM shares and 226,520 BSAAR warrants.
3. Currently, Stryker owns 8,416,399 VEXIM shares, holding 91.19 percent of the company’s share capital. Stryker owns about 91.56 percent of VEXIM’s voting rights as well.
4. VEXIM, a medical device company offering vertebral compression fracture solutions, is on the Euronext Growth stock exchange in France.
5. Opened Nov. 16, the public tender offer closed Dec. 6.
More articles on devices:
EIT secures contract with Hospital Corporation of America — 5 insights
Medtronic purchases minimally invasive device company in estimated $44.8M deal: 3 insights
Most orthopedic device educational material overly complex for patients — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.